Inventor · disambiguated record
Marco Hofmann
Also filed as: HOFMANN MARCO · HOFMANN MARCO HANS
10 granted patents·6 pending applications·15 citations·filing 2005–2022
81Inventor score
Files withBOEHRINGER INGELHEIM INT8WACKER CHEMIE AG3CSL Behring Lengnau AG2HOFMANN MARCO2ROSCHER ANJA1
Top patents by PatentIndex Score
16 records- 0184US7803893B2Hydrosilylation process in the presence of ruthenium catalyzersWACKER CHEMIE AG·Filed 2007·Granted Sep 28, 2010·7 cites·12 claims
- 0278US8124711B2Ru complexes, production and use thereofHOFMANN MARCO·Filed 2007·Granted Feb 28, 2012·5 cites·8 claims
- 0372US11198726B2Anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 14, 2021·1 cites·6 claims
- 0471US8697818B2Alkoxy-crosslinking rubber mixtures comprising niobium or tantalum condensation catalystsROSCHER ANJA·Filed 2010·Granted Apr 15, 2014·2 cites·3 claims
- 0561US2022340651A1Anti cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0659US11814380B2Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 14, 2023·0 cites·14 claims
- 0748US2024238294A1Anticancer therapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0844US11141466B2Modulation of FVIII immunogenicity by truncated VWFCSL Behring Lengnau AG·Filed 2018·Granted Oct 12, 2021·0 cites·20 claims
- 0944US2023233568A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1043US11261184B2[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 1, 2022·0 cites·16 claims
- 1143US2022249492A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1243US2022348637A1Polypeptides for inducing tolerance to factor viiiCSL Behring Lengnau AG·Filed 2020·Application pending·0 cites
- 1340US8207241B2Platinum catalysts supported on nanosize titanium dioxide, their use in hydrosilylation and compositions comprising such catalystsHOFMANN MARCO·Filed 2005·Granted Jun 26, 2012·0 cites·8 claims
- 1439US11213520B2Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jan 4, 2022·0 cites·14 claims
- 1537US2009036702A1Production of organosilanes in the presence of iridium-catalysts and cocatalystsWACKER CHEMIE AG·Filed 2005·Application pending·0 cites
- 1636US8013095B2Ru sulfoxide complexes, their preparation and useWACKER CHEMIE AG·Filed 2009·Granted Sep 6, 2011·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Marco Hofmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →